SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,287,000 | -53.2% | 37,238 | -59.4% | 0.02% | -56.4% |
| Q2 2020 | $15,573,000 | +180.7% | 91,648 | +90.6% | 0.04% | +143.8% |
| Q1 2020 | $5,547,000 | -67.8% | 48,079 | -68.1% | 0.02% | -57.9% |
| Q4 2019 | $17,204,000 | +4357.0% | 150,569 | +1268.8% | 0.04% | +3700.0% |
| Q1 2016 | $386,000 | +192.4% | 11,000 | +193.8% | 0.00% | – |
| Q1 2015 | $132,000 | -99.1% | 3,744 | -99.2% | 0.00% | -100.0% |
| Q4 2014 | $14,360,000 | -48.7% | 446,950 | -40.6% | 0.04% | -51.1% |
| Q3 2014 | $27,965,000 | +2.1% | 752,150 | +5.0% | 0.09% | +4.7% |
| Q2 2014 | $27,392,000 | -24.3% | 716,150 | -9.8% | 0.09% | -28.9% |
| Q1 2014 | $36,176,000 | +13.7% | 794,023 | -0.5% | 0.12% | +10.0% |
| Q4 2013 | $31,828,000 | -28.2% | 797,888 | -21.1% | 0.11% | -35.7% |
| Q3 2013 | $44,334,000 | +9.1% | 1,011,482 | -21.7% | 0.17% | +6.2% |
| Q2 2013 | $40,653,000 | – | 1,292,227 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |